134 related articles for article (PubMed ID: 33176471)
1. Conjunctival melanoma: Risk factors for recurrent or new tumor in 540 patients at a single ocular oncology center.
Vaidya S; Dalvin LA; Yaghy A; Pacheco R; Shields JA; Lally SE; Shields CL
Eur J Ophthalmol; 2021 Sep; 31(5):2675-2685. PubMed ID: 33176471
[TBL] [Abstract][Full Text] [Related]
2. Conjunctival melanoma: outcomes based on tumour origin in 629 patients at a single ocular oncology centre.
Pacheco RR; Yaghy A; Dalvin LA; Vaidya S; Perez AL; Lally SE; Shields JA; Shields CL
Eye (Lond); 2022 Mar; 36(3):603-611. PubMed ID: 33772241
[TBL] [Abstract][Full Text] [Related]
3. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL
Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
[TBL] [Abstract][Full Text] [Related]
4. Clinical features predictive of orbital exenteration for conjunctival melanoma.
Shields JA; Shields CL; Gündüz K; Cater J
Ophthalmic Plast Reconstr Surg; 2000 May; 16(3):173-8. PubMed ID: 10826757
[TBL] [Abstract][Full Text] [Related]
5. Conjunctival Melanoma: Outcomes Based on Age at Presentation in 629 Patients at a Single Ocular Oncology Center.
Dalvin LA; Yaghy A; Vaidya S; Pacheco RR; Perez AL; Lally SE; Shields JA; Shields CL
Cornea; 2021 May; 40(5):554-563. PubMed ID: 32740010
[TBL] [Abstract][Full Text] [Related]
6. Conjunctival Melanoma: Outcomes based on the American Joint Committee on Cancer Clinical Classification (8th Edition) of 425 Patients at a Single Ocular Oncology Center.
Shields CL; Yaghy A; Dalvin LA; Vaidya S; Pacheco RR; Perez AL; Lally SE; Shields JA
Asia Pac J Ophthalmol (Phila); 2020 Dec; 10(2):146-151. PubMed ID: 33306519
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma.
Yousef YA; Finger PT
Arch Ophthalmol; 2012 May; 130(5):599-606. PubMed ID: 22652846
[TBL] [Abstract][Full Text] [Related]
8. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL; Shields JA; Gündüz K; Cater J; Mercado GV; Gross N; Lally B
Arch Ophthalmol; 2000 Nov; 118(11):1497-507. PubMed ID: 11074806
[TBL] [Abstract][Full Text] [Related]
9. Conjunctival Melanoma in Chinese Patients: Local Recurrence, Metastasis, Mortality, and Comparisons With Caucasian Patients.
Zhou C; Wang Y; Jia R; Fan X
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5452-5459. PubMed ID: 29059312
[TBL] [Abstract][Full Text] [Related]
10. Iris melanoma: factors predictive of post-management secondary glaucoma in 271 cases at a Single Ocular Oncology Centre.
Shukla AG; Vaidya S; Yaghy A; Di Nicola M; Kaliki S; Fulco E; Myers JS; Shields JA; Shields CL
Eye (Lond); 2023 Apr; 37(5):938-946. PubMed ID: 35383310
[TBL] [Abstract][Full Text] [Related]
11. Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma.
Shields CL; Shields JA; Carvalho C; Rundle P; Smith AF
Ophthalmology; 2001 May; 108(5):979-84. PubMed ID: 11320031
[TBL] [Abstract][Full Text] [Related]
12. Conjunctival Melanoma: Features and Outcomes Based on the Fitzpatrick Skin Type in 540 Patients at a Single Ocular Oncology Center.
Shields CL; Yaghy A; Dalvin LA; Vaidya S; Pacheco RR; Perez AL; Ramesh S; George K; Arias DE; Shiuey EJ; Lally SE; Shields JA
Ophthalmic Plast Reconstr Surg; 2020; 36(5):490-496. PubMed ID: 32134771
[TBL] [Abstract][Full Text] [Related]
13. Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications for Future AJCC Classifications.
Esmaeli B; Rubin ML; Xu S; Goepfert RP; Curry JL; Prieto VG; Ning J; Tetzlaff MT
Am J Surg Pathol; 2019 Dec; 43(12):1701-1710. PubMed ID: 31425167
[TBL] [Abstract][Full Text] [Related]
14. [Pathology and prognostic factors of conjunctival melanoma].
Berta-Antalics AI; Kruse FE; Holbach L
Ophthalmologe; 2015 Nov; 112(11):892, 894-8. PubMed ID: 26531292
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features Differentiating Benign From Malignant Conjunctival Tumors in Children.
Shields CL; Sioufi K; Alset AE; Boal NS; Casey MG; Knapp AN; Sugarman JA; Schoen MA; Gordon PS; Say EA; Shields JA
JAMA Ophthalmol; 2017 Mar; 135(3):215-224. PubMed ID: 28125759
[TBL] [Abstract][Full Text] [Related]
16. Conjunctival Melanoma in 430 Cases: Comparative Analysis of the Impact of Orbital Invasion on Tumor Recurrence, Metastasis, and Death.
Bas Z; Dockery PW; Lally SE; Shields JA; Shields CL
Ophthalmic Plast Reconstr Surg; 2023 Jan-Feb 01; 39(1):49-57. PubMed ID: 36598390
[TBL] [Abstract][Full Text] [Related]
17. Conjunctival melanoma: Insights into classification, outcomes, and biomarkers.
Shields CL; Silva AMV; Laiton A; Kalafatis NE; Schiller E; Lally SE; Grant-Kels JM; Shields JA
Clin Dermatol; 2024; 42(1):46-55. PubMed ID: 37858779
[TBL] [Abstract][Full Text] [Related]
18. Conjunctival melanoma in the Netherlands: a nationwide study.
Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757
[TBL] [Abstract][Full Text] [Related]
19. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
20. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study.
Jain P; Finger PT; Fili M; Damato B; Coupland SE; Heimann H; Kenawy N; J Brouwer N; Marinkovic M; Van Duinen SG; Caujolle JP; Maschi C; Seregard S; Pelayes D; Folgar M; Yousef YA; Krema H; Gallie B; Calle-Vasquez A;
Br J Ophthalmol; 2021 Oct; 105(10):1358-1364. PubMed ID: 32892167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
